Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 11/20 | 0.58 |
| ▸ | CASP2 | P42575 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1273739 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL10960588 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL10961098 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL1273855 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL10962041 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL22622093 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL10487390 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL1272676 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL10960416 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL1273282 | 1.00 | EPHX1 (0.58) | EPHX1CASP2ZDHHC20ZDHHC2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1661586-B1 | Disinfecting substrate | BODE CHEMIE GMBH (DE) | 2010-08-04 | — | — | EP | claimed |
| US-20060134056-A1 | Use of alkylguanidines as cationic emulsifiers | GOLDSCHMIDT AG (DE) | 2006-06-22 | — | — | US | disclosed |
| EP-1671615-A2 | Use of alkyl guanidines as cationic emulsifiers | Goldschmidt GmbH (DE) | 2006-06-21 | — | — | EP | disclosed |
| US-4497887-A | Thermal development type diazo copying material with hydrophobic resin encapsulated coupler particle | Ricoh Compay, Ltd. (JP) | 1985-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060134056-A1 | Use of alkylguanidines as cationic emulsifiers | HBG2, GPR18, AAAS | EPHX1 1839/4885CASP2 1701/4885ZDHHC20 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.